Loading...
A-
A+

Fonts Size

Change Color

Alert:

20 May 2022 DoH urges all healthcare facilities operating in the emirate to be vigilant about any suspected or confirmed Monkeypox cases to find out more Click Here

DOH urges all healthcare and pharmaceutical facilities & Health professional to Adhere to the circular number(63\2021) by updating the details of the mobile number & e-mail address in order to receive all circulars & letters issued by DOH, for more information Click Here

1845 samples analyzed

Enhancing regulatory oversight on medicinal products sold in Abu Dhabi

Establish Prescribers and Consumer confidence on Generic versions of pharmaceutical products

Periodic laboratory testing to ensure the quality of medicines distributed in Abu Dhabi

Improve patient safety by removing unsafe and sub-standard

5 Years Action Plan

Risk Management Framework

Our five years plan will address risks associated with the availability of non- registered medications in Abu Dhabi Market And will also assess generics efficacy

Five Years Plan

Highly consumed products

Chronic medication blood pressure, cholesterol, antibiotic

Critical drugs

Critical drugs - Antidote, cardiac arrest, antiplatelet

Non registered medicines

Products with quality issues

market Complaints and intentional issues

Studies Summary 2016-2020

Injections NR 843 Samples For 66 products

Azitromycin 228 Samples For 32 products

Atorvastain 74 Samples For 37 products

Antibiotic 128 Samples For 23 products

Azitromycin 228 Samples For 32 products

Subscribe for updates

Thanks for Subscribing

Last updated: 28 Nov 2022

Mobile For an optimal experience please
rotate your device to portrait mode